{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:38Z","timestamp":1786980578813,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10157-025-02762-0","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T09:42:59Z","timestamp":1756978979000},"page":"1456-1464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Combined effect of hyperhomocysteinemia and mild-to-moderate chronic kidney disease on mortality and cardiovascular events in the Japanese general population: the Yamagata (Takahata) study"],"prefix":"10.1007","volume":"29","author":[{"given":"Tomohiro","family":"Takehara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7859-1427","authenticated-orcid":false,"given":"Yoichiro","family":"Otaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzuka","family":"Kuramasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Nawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Matsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayumi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunobu","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneo","family":"Konta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"2762_CR1","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","volume":"338","author":"GN Welch","year":"1998","unstructured":"Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998;338:1042\u201350.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"2762_CR2","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1038\/sj.cdd.4401451","volume":"11","author":"RC Austin","year":"2004","unstructured":"Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ. 2004;11(Suppl 1):S56-64.","journal-title":"Cell Death Differ"},{"key":"2762_CR3","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1161\/CIRCULATIONAHA.109.866889","volume":"120","author":"D Zhang","year":"2009","unstructured":"Zhang D, Jiang X, Fang P, Yan Y, Song J, Gupta S, et al. Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice. Circulation. 2009;120:1893\u2013902.","journal-title":"Circulation"},{"key":"2762_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3949\/ccjm.77a.10036","volume":"77","author":"JM Abraham","year":"2010","unstructured":"Abraham JM, Cho L. The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease? Cleve Clin J Med. 2010;77:911\u20138.","journal-title":"Cleve Clin J Med"},{"key":"2762_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s10753-018-0873-9","volume":"42","author":"H Hu","year":"2019","unstructured":"Hu H, Wang C, Jin Y, Meng Q, Liu Q, Liu Z, et al. Catalpol inhibits homocysteine-induced oxidation and inflammation via inhibiting Nox4\/NF-\u03baB and GRP78\/PERK pathways in human aorta endothelial cells. Inflammation. 2019;42:64\u201380.","journal-title":"Inflammation"},{"key":"2762_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41392-023-01313-x","volume":"8","author":"X Du","year":"2023","unstructured":"Du X, Ma X, Tan Y, Shao F, Li C, Zhao Y, et al. B cell-derived anti-beta 2 glycoprotein I antibody mediates hyperhomocysteinemia-aggravated hypertensive glomerular lesions by triggering ferroptosis. Signal Transduct Target Ther. 2023;8:103.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2762_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1182\/bloodadvances.2021004572","volume":"6","author":"L Han","year":"2022","unstructured":"Han L, Miao Y, Zhao Y, Zhang X, Ma X, Du X, et al. The binding of autotaxin to integrins mediates hyperhomocysteinemia-potentiated platelet activation and thrombosis in mice and humans. Blood Adv. 2022;6(1):46\u201361.","journal-title":"Blood Adv"},{"key":"2762_CR8","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","volume":"288","author":"Homocysteine Studies Collaboration","year":"2002","unstructured":"Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. JAMA. 2002;288:2015.","journal-title":"JAMA"},{"key":"2762_CR9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","volume":"268","author":"MJ Stampfer","year":"1992","unstructured":"Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877\u201381.","journal-title":"JAMA"},{"key":"2762_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S0002-8703(00)90088-7","volume":"139","author":"WH Giles","year":"2000","unstructured":"Giles WH, Croft JB, Greenlund KJ, Ford ES, Kittner SJ. Association between total homocyst(e)ine and the likelihood for a history of acute myocardial infarction by race and ethnicity: results from the third national health and nutrition examination survey. Am Heart J. 2000;139:446\u201353.","journal-title":"Am Heart J"},{"key":"2762_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1631\/jzus.B1400183","volume":"16","author":"H Peng","year":"2015","unstructured":"Peng H, Man C, Xu J, Fan Y. Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies. J Zhejiang Univ Sci B. 2015;16:78\u201386.","journal-title":"J Zhejiang Univ Sci B"},{"key":"2762_CR12","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1038\/s41598-017-05205-3","volume":"7","author":"R Fan","year":"2017","unstructured":"Fan R, Zhang A, Zhong F. Association between homocysteine levels and all-cause mortality: a dose-response meta-analysis of prospective studies. Sci Rep. 2017;7:4769.","journal-title":"Sci Rep"},{"key":"2762_CR13","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet. 2021;398:786\u2013802.","journal-title":"Lancet"},{"key":"2762_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395:709\u201333.","journal-title":"Lancet"},{"key":"2762_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","volume":"94","author":"Y Xie","year":"2018","unstructured":"Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, et al. Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94:567\u201381.","journal-title":"Kidney Int"},{"key":"2762_CR16","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105:S117-314.","journal-title":"Kidney Int"},{"key":"2762_CR17","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2023.17002","volume":"330","author":"ME Grams","year":"2023","unstructured":"Writing Group for the CKD Prognosis Consortium, Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, et al. Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis. JAMA. 2023;330:1266\u201377.","journal-title":"JAMA"},{"key":"2762_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1523-1755.2004.00732.x","volume":"66","author":"ME Francis","year":"2004","unstructured":"Francis ME, Eggers PW, Hostetter TH, Briggs JP. Association between serum homocysteine and markers of impaired kidney function in adults in the United States. Kidney Int. 2004;66:303\u201312.","journal-title":"Kidney Int"},{"key":"2762_CR19","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s40620-019-00618-x","volume":"32","author":"E Cohen","year":"2019","unstructured":"Cohen E, Margalit I, Shochat T, Goldberg E, Krause I. The relationship between the concentration of plasma homocysteine and chronic kidney disease: a cross sectional study of a large cohort. J Nephrol. 2019;32:783\u20139.","journal-title":"J Nephrol"},{"key":"2762_CR20","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/ndt\/gfv380","volume":"31","author":"JD Spence","year":"2016","unstructured":"Spence JD, Urquhart BL, Bang H. Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine. Nephrol Dial Transplant. 2016;31:937\u201344.","journal-title":"Nephrol Dial Transplant"},{"key":"2762_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1159\/000514360","volume":"46","author":"W Xiao","year":"2021","unstructured":"Xiao W, Ye P, Wang F, Cao R, Bai Y, Wang X. Plasma homocysteine is a predictive factor for accelerated renal function decline and chronic kidney disease in a community-dwelling population. Kidney Blood Press Res. 2021;46:541\u20139.","journal-title":"Kidney Blood Press Res"},{"key":"2762_CR22","first-page":"170","volume":"23","author":"P Jungers","year":"1997","unstructured":"Jungers P, Chauveau P, Bandin O, Chadefaux B, Aupetit J, Labrunie M, et al. Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients. Miner Electrolyte Metab. 1997;23:170\u20133.","journal-title":"Miner Electrolyte Metab"},{"key":"2762_CR23","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1161\/CIRCULATIONAHA.105.570127","volume":"113","author":"V Menon","year":"2006","unstructured":"Menon V, Sarnak MJ, Greene T, Wang X, Pereira AA, Beck GJ, et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation. 2006;113:1572\u20137.","journal-title":"Circulation"},{"key":"2762_CR24","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"2762_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cccn.2004.11.028","volume":"354","author":"MD Kellogg","year":"2005","unstructured":"Kellogg MD, Parker R, Ricupero A, Rifai N. Evaluation of an enzymatic homocysteine assay for the Hitachi series chemistry analyzer. Clin Chim Acta. 2005;354:117\u201322.","journal-title":"Clin Chim Acta"},{"key":"2762_CR26","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.3390\/nu16121945","volume":"16","author":"Z Liang","year":"2024","unstructured":"Liang Z, Li K, Chen H, Jia J, Li J, Huo Y, et al. The association of plasma homocysteine concentrations with a 10-year risk of all-cause and cardiovascular mortality in a community-based Chinese population. Nutrients. 2024;16:1945.","journal-title":"Nutrients"},{"key":"2762_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2020.100515","author":"T Toya","year":"2020","unstructured":"Toya T, Sara JD, Lerman B, Ahmad A, Taher R, Godo S, et al. Elevated plasma homocysteine levels are associated with impaired peripheral microvascular vasomotor response. IJC Heart Vasc. 2020. https:\/\/doi.org\/10.1016\/j.ijcha.2020.100515.","journal-title":"IJC Heart Vasc"},{"key":"2762_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00380-021-01903-1","volume":"37","author":"Y Otaki","year":"2022","unstructured":"Otaki Y, Watanabe T, Goto J, Wanezaki M, Kato S, Tamura H, et al. Association between thrombolysis in myocardial infarction grade and clinical outcome after emergent percutaneous coronary intervention in patients with acute myocardial infarction who have suffered out-of-hospital cardiac arrest: the Yamagata AMI registry. Heart Vessels. 2022;37:40\u20139.","journal-title":"Heart Vessels"},{"key":"2762_CR29","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s41440-024-01613-x","volume":"47","author":"C Ding","year":"2024","unstructured":"Ding C, Li J, Wei Y, Fan W, Cao T, Chen Z, et al. Associations of total homocysteine and kidney function with all-cause and cause-specific mortality in hypertensive patients: a mediation and joint analysis. Hypertens Res. 2024;47:1500\u201311.","journal-title":"Hypertens Res"},{"key":"2762_CR30","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1001\/jamainternmed.2016.4687","volume":"176","author":"X Xu","year":"2016","unstructured":"Xu X, Qin X, Li Y, Sun D, Wang J, Liang M, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease. JAMA Intern Med. 2016;176:1443.","journal-title":"JAMA Intern Med"},{"key":"2762_CR31","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","volume":"298","author":"RL Jamison","year":"2007","unstructured":"Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA. 2007;298:1163\u201370.","journal-title":"JAMA"},{"key":"2762_CR32","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1001\/jama.2010.490","volume":"303","author":"AA House","year":"2010","unstructured":"House AA, Eliasziw M, Cattran DC, Churchill DN, Oliver MJ, Fine A, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA. 2010;303:1603\u20139.","journal-title":"JAMA"},{"key":"2762_CR33","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/ndt\/gfm485","volume":"23","author":"JFE Mann","year":"2008","unstructured":"Mann JFE, Sheridan P, McQueen MJ, Held C, Arnold JMO, Fodor G, et al. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease\u2013results of the renal Hope-2 study. Nephrol Dial Transplant. 2008;23:645\u201353.","journal-title":"Nephrol Dial Transplant"},{"key":"2762_CR34","unstructured":"National Institute of Health: Folate Fact Sheet for Health Professionals. https:\/\/ods.od.nih.gov\/factsheets\/Folate-HealthProfessional\/?utm_source=chatgpt.com#h6 Accessed 2 Aug 2025."},{"key":"2762_CR35","unstructured":"L and W Ministry of Health: Overview of the Results of the 2023 National Health and Nutrition Survey. https:\/\/www.mhlw.go.jp\/content\/10900000\/001338334.pdf Accessed 2 Aug 2025."},{"key":"2762_CR36","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1017\/S1368980014002134","volume":"18","author":"R Zeng","year":"2015","unstructured":"Zeng R, Xu C-H, Xu Y-N, Wang Y-L, Wang M. The effect of folate fortification on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis. Public Health Nutr. 2015;18:1514\u201321.","journal-title":"Public Health Nutr"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02762-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02762-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02762-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:38:28Z","timestamp":1758789508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02762-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2762"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02762-0","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (IRB approval number: Yamagata University, 2025\u201395) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all the participants in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal participants"}}]}}